| |
Total
|
Part 1
|
Part 2
|
|---|
| |
Mean (%)
|
95% CI
|
Mean (%)
|
95% CI
|
Mean (%)
|
95% CI
|
|---|
|
Total
|
17.2
|
14.9 – 19.5
|
27.9°
|
24.0 – 31.7
|
6.5
|
4.6 – 8.4
|
|
Female
|
16.5
|
14.2 – 18.9
|
25.9
|
22.0 – 29.8
|
6.8
|
4.9 – 8.7
|
|
Male
|
17.9
|
15.2 – 20.6
|
29.8
#
|
25.3 – 34.4
|
6.1
|
3.8 – 8.4
|
|
Case 1
|
12.1**
|
6.9 – 17.4
|
20.0**
|
11.3 – 28.7
|
5.5
|
1.2 – 9.7
|
|
Case 2
|
16.6
|
11.3 – 21.8
|
25.5
|
16.8 – 34.1
|
9.1
|
4.8 – 13.3
|
|
Case 3
|
6.9*
|
2.3 – 11.6
|
13.8*
|
6.1 – 25.5
|
1.7
|
-2.1 – 5.5
|
|
Case 4
|
26.9
|
21.6 – 32.1
|
42.1
|
33.4 – 50.8
|
7.7
|
3.5 – 12.0
|
|
Case 5
|
23.5
|
18.2 – 28.8
|
37.9
|
29.1 – 46.6
|
8.4
|
4.1 – 12.7
|
- Part 1 = patient’s symptoms, Part 2 = further history. *: Significant difference versus cases 4 and 5 (p < .01), **: Significant difference versus case 4 (p < .05). #: Significant difference male versus female (p < .05), °: Significant difference part 1 versus part 2 (p < .01).
